How States Are Working to Control Prescription Drug Costs

Washington is focusing on innovation, while states are putting their efforts into cutting costs.

WASHINGTON - JULY 29: U.S. Rep. Gene Green (D-TX) speaks during a hearing regarding the alleged ethics breaches by Rep. Charles Rangel (D-NY) before the House Committee on Standards of Official Conduct July 29, 2010 on Capitol Hill in Washington, DC. The Investigative Subcommittee of the House committee has announced 13 ethics charges against Rangel. (Photo by Alex Wong/Getty Images)
National Journal

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.